Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jiangsu Cai Qin Technology
688182
5
Dalian Dalicap Technology
301566
US OptionsDetailed Quotes
AMPH250417P20000
- 0.15
- 0.000.00%
15min DelayClose Apr 17 16:00 ET
0.00High0.00Low
0.15Open0.15Pre Close0 Volume1 Open Interest20.00Strike Price0.00Turnover0.00%IV14.99%PremiumApr 17, 2025Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma155.67Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Amphastar Pharmaceuticals Newsroom
Needham Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating
Amphastar Pharmaceuticals Is Maintained at Neutral by Piper Sandler
Amphastar Pharma Analyst Ratings
Piper Sandler Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Cuts Target Price to $32
A Quick Look at Today's Ratings for Amphastar Pharmaceuticals(AMPH.US), With a Forecast Between $36 to $40
Piper Sandler Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Maintains Target Price $36
Wells Fargo Maintains Amphastar Pharmaceuticals(AMPH.US) With Buy Rating, Cuts Target Price to $40
Needham Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating
J.P. Morgan Maintains Amphastar Pharmaceuticals(AMPH.US) With Buy Rating, Cuts Target Price to $45
Piper Sandler Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Maintains Target Price $36
Amphastar Pharmaceuticals Cut to Neutral From Overweight by Piper Sandler
Amphastar Pharma Analyst Ratings
Piper Sandler Downgrades Amphastar Pharmaceuticals(AMPH.US) to Hold Rating, Cuts Target Price to $36
BofA Securities Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Cuts Target Price to $44
Amphastar Pharmaceuticals (AMPH) Gets a Hold From Bank of America Securities
Amphastar Pharma Analyst Ratings
Wells Fargo Initiates Amphastar Pharmaceuticals(AMPH.US) With Buy Rating, Announces Target Price $55
Piper Sandler Maintains Amphastar Pharmaceuticals(AMPH.US) With Buy Rating, Maintains Target Price $66
Needham Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating
Capital One Financial Maintains Amphastar Pharmaceuticals(AMPH.US) With Buy Rating, Maintains Target Price $70
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call